Heating up IDH-mutant gliomas
A recent study unpicks a key immune-mediated mechanism of mutant IDH-blocking drugs such as vorasidenib in the treatment of IDH-mutant glioma.
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
December 5, 2024
|
| In: |
The New England journal of medicine
Year: 2024, Volume: 391, Issue: 22, Pages: 2170-2172 |
| ISSN: | 1533-4406 |
| DOI: | 10.1056/NEJMcibr2410562 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1056/NEJMcibr2410562 Verlag, lizenzpflichtig, Volltext: https://www.nejm.org/doi/full/10.1056/NEJMcibr2410562 
|
| Author Notes: | Michael Platten, M.D., and Lukas Bunse, M.D., Ph.D. |
| Summary: | A recent study unpicks a key immune-mediated mechanism of mutant IDH-blocking drugs such as vorasidenib in the treatment of IDH-mutant glioma. |
|---|---|
| Item Description: | Gesehen am 14.03.2025 |
| Physical Description: | Online Resource |
| ISSN: | 1533-4406 |
| DOI: | 10.1056/NEJMcibr2410562 |